The Material Change is that this stock is way undervalued. The material change is that the stock is grossly undervalued and can easily double or triple any day - for starters. It is currently has a market cap not even half of annual revenue.
Gross Profit, excluding changes in fair value of biological assets US$13.9
Net Income(loss) US$26.1
Adjusted EBITDA US$2.7
Gros profit for TILT last quarter was US $13.9 Million - They can get EBITDA closer to this number - it will give TILT annual $55.6 EBITDA and a $550 million USD valuation if a conservative 10xEBITDA. If it was more like other cannabis companies in the market 10x earnings - then closer to 1.6 Billion valuation.
This EBITDA valuation will bring the stock price closer to a minimum of $1,80 USD or $2.50 CAD. This may occur sooner than later when we see Q1 results. If it is an earnings valuation - like other cannabis companies - may see a $5.30 USD stock price or $7.46 Canadian.